PW MEDTECH (01358): Proposed termination of listing for Sichuan Ruijian Medical

PW MEDTECH (01358) announces that the board of directors of the Company recently received a notice from Sichuan Ruijian Medical Technology Co., Ltd. (Sichuan Ruijian Medical, a non-wholly-owned subsidiary of the Company, whose shares are listed on the National Equities Exchange and Quotations (NEEQ), stock code: 874652), informing that on October 21, 2026, the board of directors of Sichuan Ruijian Medical resolved: (i) to propose the voluntary termination of the listing of Sichuan Ruijian Medical shares on the NEEQ; (ii) to take measures to protect the rights and interests of shareholders of Sichuan Ruijian Medical who dissent from the proposed termination of listing; (iii) to seek authorization from the shareholders of Sichuan Ruijian Medical for its board of directors to handle all matters relating to the proposed termination of listing; (iv) to convene the fifth extraordinary general meeting of shareholders of Sichuan Ruijian Medical in 2026, expected to be held on November 6, 2026, to consider and, as appropriate, approve the above matters. Sichuan Ruijian Medical is a medical device company principally engaged in the research and development, manufacturing and sales of blood purification medical devices. As at the date of this announcement, the Company indirectly holds approximately 53.10% of the total issued shares of Sichuan Ruijian Medical, and Sichuan Ruijian Medical is a non-wholly-owned subsidiary of the Company, whose financial results are consolidated into the Group's financial statements.